Top compounds associated with response to BHLHB9


Feature Type Standardized
Nominal ANOVA
mRNA ZSTK474 GDSC1000 pan-cancer AAC 0.015 0.7
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC 0.028 0.7
mRNA rigosertib CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.017 0.7
mRNA paclitaxel GDSC1000 pan-cancer AAC 0.027 0.7
mRNA ouabain CTRPv2 pan-cancer AAC -0.016 0.7
mRNA GDC-0941 gCSI pan-cancer AAC -0.03 0.7
mRNA SR1001 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.021 0.7
Download CSV